Insider Trading Alert - ATI, CAH And CCI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 8, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $460.00 to $19,915,560.00.

Highlighted Stocks Traded by Insiders:

Allegheny Technologies (ATI) - FREE Research Report

Schwartz Karl D, who is Controller & Chief Acctg Off at Allegheny Technologies, sold 750 shares at $41.03 on May 8, 2014. Following this transaction, the Controller & Chief Acctg Off owned 26,205 shares meaning that the stake was reduced by 2.78% with the 750-share transaction.

The shares most recently traded at $41.56, up $0.53, or 1.28% since the insider transaction. Historical insider transactions for Allegheny Technologies go as follows:

  • 24-Week # shares sold: 1,500

The average volume for Allegheny Technologies has been 1.5 million shares per day over the past 30 days. Allegheny Technologies has a market cap of $4.5 billion and is part of the industrial goods sector and industrial industry. Shares are up 18.02% year-to-date as of the close of trading on Thursday.

Allegheny Technologies Incorporated produces and sells specialty materials and components worldwide. The company operates through two segments, High Performance Metals and Flat-Rolled Products. The stock currently has a dividend yield of 1.74%. Currently, there are 3 analysts who rate Allegheny Technologies a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATI - FREE

TheStreet Quant Ratings rates Allegheny Technologies as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and poor profit margins. Get the full Allegheny Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cardinal Health (CAH) - FREE Research Report

Henderson Jeffrey William, who is Chief Financial Officer at Cardinal Health, sold 27,031 shares at $63.83 on May 8, 2014. Following this transaction, the Chief Financial Officer owned 107,096 shares meaning that the stake was reduced by 20.15% with the 27,031-share transaction.

The shares most recently traded at $63.89, up $0.06, or 0.09% since the insider transaction. Historical insider transactions for Cardinal Health go as follows:

  • 4-Week # shares sold: 2,330
  • 12-Week # shares sold: 2,330
  • 24-Week # shares sold: 86,859

The average volume for Cardinal Health has been 2.3 million shares per day over the past 30 days. Cardinal Health has a market cap of $21.7 billion and is part of the services sector and wholesale industry. Shares are down 4.36% year-to-date as of the close of trading on Thursday.

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The stock currently has a dividend yield of 2.15%. The company has a P/E ratio of 64.5. Currently, there are 12 analysts who rate Cardinal Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAH - FREE

TheStreet Quant Ratings rates Cardinal Health as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cardinal Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Crown Castle International (CCI) - FREE Research Report

Young James D, who is SVP & Chief Operating Officer at Crown Castle International, sold 8,665 shares at $77.02 on May 8, 2014. Following this transaction, the SVP & Chief Operating Officer owned 221,010 shares meaning that the stake was reduced by 3.77% with the 8,665-share transaction.

The shares most recently traded at $76.94, down $0.08, or 0.1% since the insider transaction. Historical insider transactions for Crown Castle International go as follows:

  • 4-Week # shares sold: 11,127
  • 12-Week # shares sold: 11,127
  • 24-Week # shares sold: 11,127

The average volume for Crown Castle International has been 2.4 million shares per day over the past 30 days. Crown Castle International has a market cap of $25.9 billion and is part of the technology sector and telecommunications industry. Shares are up 5.13% year-to-date as of the close of trading on Thursday.

Crown Castle International Corp., together with its subsidiaries, owns, operates, and leases shared wireless infrastructure in the United States and Australia. The stock currently has a dividend yield of 1.8%. The company has a P/E ratio of 161.9. Currently, there are 10 analysts who rate Crown Castle International a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCI - FREE

TheStreet Quant Ratings rates Crown Castle International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Crown Castle International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing